July 11, 2012 — Lantheus Medical Imaging Inc., a developer, manufacturer and distributor of diagnostic imaging agents, announced the publication of results from the CaRES (Contrast Echocardiography Registry for Safety Surveillance) multicenter safety registry for its ultrasound imaging agent Definity Vial for (Perflutren Lipid Microsphere) Injectable Suspension.

July 11, 2012 — Biotronik, a manufacturer of innovative medical technology, announced that enrollment is now complete for the much anticipated SPIRIT-ICD study, with 503 patients from 37 sites in 11 countries worldwide registered.

July 11, 2012 — St. Jude Medical received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ViewFlex Xtra intracardiac echocardiography (ICE) catheter.

July 10, 2012 — In CT (computed tomography) imaging, healthcare facilities strive to limit patient radiation dose while maintaining high image quality for accurate diagnoses. St. Elizabeth Healthcare, in Edgewood, Ky., is the first facility to be upgraded with Toshiba’s advanced dose reduction software, AIDR 3D, on its Aquilion ONE CT system.


July 10, 2012 — A study led by researchers at the University of California, San Francisco (UCSF) and the Group Health Research Institute (GHRI) shows that medical imaging is increasing even in health maintenance organization systems (HMOs), which don’t have a financial incentive to conduct them.

July 10, 2012 — Based on its recent analysis of workflow solutions for the computed tomography (CT) imaging market, Frost & Sullivan recognized Siemens Healthcare with the 2012 North American Frost & Sullivan Award for Customer Value Enhancement.

July 10, 2012 — New and updated evidence-based guidelines to help healthcare providers choose the most appropriate medical imaging exam or radiation therapy for a patient’s clinical condition are now available via the latest version of the American College of Radiology (ACR) Appropriateness Criteria. These continually updated criteria are a national standard, developed by expert panels of physicians from many different medical specialties.

July 9, 2012 — r4 Vascular Inc. announced clearance from the U.S. Food and Drug Administration (FDA) to market the Vector percutaneous transluminal angioplasty (PTA) balloon catheters in 28 sizes.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now